BrainChild Bio Initiates Pivotal Phase 2 Trial of BCB-276 for DIPG
SEATTLE, Washington and CAMBRIDGE, Massachusetts — September 8, 2026 BrainChild Bio, Inc. announced the initiation of the pivotal Phase...
DIPG
Advertisement
Advertisement
